CHIP-ing Away at Post-Transplant Outcomes: the Role of Somatic Mutations in Heart Transplant Outcomes.
作者信息
Regan Jessica A, Shah Svati H
机构信息
Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina.
Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina; Duke Center for Precision Health, Duke University School of Medicine, Durham, North Carolina.
出版信息
J Card Fail. 2025 Feb;31(2):411-414. doi: 10.1016/j.cardfail.2024.12.002. Epub 2024 Dec 20.
Abstract
摘要
相似文献
1
CHIP-ing Away at Post-Transplant Outcomes: the Role of Somatic Mutations in Heart Transplant Outcomes.逐步改善移植后结局：体细胞突变在心脏移植结局中的作用
J Card Fail. 2025 Feb;31(2):411-414. doi: 10.1016/j.cardfail.2024.12.002. Epub 2024 Dec 20.
2
Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients.肺移植受者中不确定潜能克隆性造血的流行率和意义。
BMC Pulm Med. 2023 Oct 30;23(1):414. doi: 10.1186/s12890-023-02703-1.
3
Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation.意义未明的克隆性造血与心脏移植的长期预后
J Card Fail. 2025 Feb;31(2):400-410. doi: 10.1016/j.cardfail.2024.05.011. Epub 2024 Jun 15.
4
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.导致克隆性造血突变与慢性缺血性心力衰竭预后的关联。
JAMA Cardiol. 2019 Jan 1;4(1):25-33. doi: 10.1001/jamacardio.2018.3965.
5
Clonal hematopoiesis of indeterminate potential and outcomes after heart transplantation: A multicenter study.克隆性造血不定潜能与心脏移植后结局：一项多中心研究。
Am J Transplant. 2023 Aug;23(8):1256-1263. doi: 10.1016/j.ajt.2023.04.028. Epub 2023 May 6.
6
'Chip'-ing away at morphogenesis - application of organ-on-chip technologies to study tissue morphogenesis.'芯片'技术在形态发生中的应用 - 器官芯片技术在研究组织形态发生中的应用。
J Cell Sci. 2023 Oct 1;136(19). doi: 10.1242/jcs.261130. Epub 2023 Oct 5.
7
Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.体细胞突变和克隆性造血作为与年龄相关的心血管风险的驱动因素。
Curr Cardiol Rep. 2022 Aug;24(8):1049-1058. doi: 10.1007/s11886-022-01724-2. Epub 2022 Jun 3.
8
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia.杀伤免疫球蛋白样受体和体细胞突变对急性髓系白血病移植结局的影响。
Transplant Cell Ther. 2021 Nov;27(11):917.e1-917.e9. doi: 10.1016/j.jtct.2021.08.002. Epub 2021 Aug 8.
9
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions.克隆性造血：现状与未来方向。
Curr Oncol Rep. 2023 Jun;25(6):539-547. doi: 10.1007/s11912-023-01382-9. Epub 2023 Mar 16.
10
Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.意义未明的克隆性造血与心房颤动：一项东亚队列研究。
Eur Heart J. 2024 Mar 7;45(10):778-790. doi: 10.1093/eurheartj/ehad869.
本文引用的文献
1
Clonal Hematopoiesis of Indeterminate Potential and Long-term Outcomes in Heart Transplantation.意义未明的克隆性造血与心脏移植的长期预后
J Card Fail. 2025 Feb;31(2):400-410. doi: 10.1016/j.cardfail.2024.05.011. Epub 2024 Jun 15.
2
Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.自体造血干细胞移植治疗淋巴和非淋巴系统疾病后，由克隆性造血衍生的治疗相关髓系肿瘤。
Leukemia. 2024 Jun;38(6):1266-1274. doi: 10.1038/s41375-024-02258-y. Epub 2024 Apr 29.
3
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1.TET2 和 ASXL1 中的心房颤动和克隆性造血
JAMA Cardiol. 2024 Jun 1;9(6):497-506. doi: 10.1001/jamacardio.2024.0459.
4
Solid Organ Transplant Recipients Exhibit More TET2-Mutant Clonal Hematopoiesis of Indeterminate Potential Not Driven by Increased Transplantation Risk.实体器官移植受者表现出更多非由移植风险增加驱动的 TET2 突变型不确定潜能克隆性造血。
Clin Cancer Res. 2024 Jun 3;30(11):2475-2485. doi: 10.1158/1078-0432.CCR-23-3840.
5
The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.国际原发性移植物功能障碍联合会：在心脏移植的当代时代重新定义临床风险因素。
J Card Fail. 2024 Jun;30(6):805-815. doi: 10.1016/j.cardfail.2023.09.018. Epub 2023 Oct 30.
6
Clonal hematopoiesis of indeterminate potential and outcomes after heart transplantation: A multicenter study.克隆性造血不定潜能与心脏移植后结局：一项多中心研究。
Am J Transplant. 2023 Aug;23(8):1256-1263. doi: 10.1016/j.ajt.2023.04.028. Epub 2023 May 6.
7
Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.克隆性造血会增加原位心脏移植受者的死亡风险。
Am J Transplant. 2022 Dec;22(12):3078-3086. doi: 10.1111/ajt.17172. Epub 2022 Aug 26.
8
Donor Macrophages Modulate Rejection After Heart Transplantation.供体巨噬细胞调节心脏移植后的排斥反应。
Circulation. 2022 Aug 23;146(8):623-638. doi: 10.1161/CIRCULATIONAHA.121.057400. Epub 2022 Jul 26.
9
Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects.克隆性造血的纵向动力学确定了基因特异性的适应性影响。
Nat Med. 2022 Jul;28(7):1439-1446. doi: 10.1038/s41591-022-01883-3. Epub 2022 Jul 4.
10
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.TET2 驱动的克隆性造血与卡那奴单抗反应：CANTOS 随机临床试验的探索性分析。
JAMA Cardiol. 2022 May 1;7(5):521-528. doi: 10.1001/jamacardio.2022.0386.
Zotero 插件